Michael Panzara
2016
In 2016, Michael Panzara earned a total compensation of $2.8M as Chief Medical Officer at Wave Life Sciences Ltd..
Compensation breakdown
| Bonus | $55,000 |
|---|---|
| Non-Equity Incentive Plan | $162,200 |
| Option Awards | $1,857,366 |
| Salary | $193,534 |
| Stock Awards | $493,448 |
| Other | $496 |
| Total | $2,762,044 |
Panzara received $1.9M in option awards, accounting for 67% of the total pay in 2016.
Panzara also received $55K in bonus, $162.2K in non-equity incentive plan, $193.5K in salary, $493.4K in stock awards and $496 in other compensation.
Rankings
In 2016, Michael Panzara's compensation ranked 3,521st out of 14,075 executives tracked by ExecPay. In other words, Panzara earned more than 75.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,521 out of 14,075 | 75th |
Division Manufacturing | 1,224 out of 5,488 | 78th |
Major group Chemicals And Allied Products | 368 out of 1,900 | 81st |
Industry group Drugs | 267 out of 1,543 | 83rd |
Industry Pharmaceutical Preparations | 211 out of 1,173 | 82nd |
Source: SEC filing on June 26, 2019.
Panzara's colleagues
We found two more compensation records of executives who worked with Michael Panzara at Wave Life Sciences Ltd. in 2016.